Drug Pipeline News:


 
Novartis: Diovan + Diuretic Reduces Artery Ageing 6/9/2008

Swiss drugmaker Novartis AG (NVS) said Thursday that a study published in the latest issue of ...

Pfizer, Avant Report Positive Results In Brain Cancer Vaccine 6/9/2008

Two small midstage studies of an experimental therapy being developed by Avant ...

UK Drug Body:Sanofi-Aventis Acomplia Linked To 5 UK Deaths 6/9/2008

Sanofi-Aventis SA's (SNY) anti-obesity pill Acomplia has been linked to five deaths and 720 ...

Recent Data Prompts Revision Of Erbitux, Avastin Study 6/9/2008

Recently released data is prompting the revision of a large study comparing the use of Imclone ...

Novartis To Continue Multiple Sclerosis Drug Trials 6/9/2008

Swiss drugmaker Novartis AG (NVS) said Thursday it will continue with trials for its oral ...

Bristol-Myers, AstraZeneca Diabetes Drug Effective In Study 6/9/2008

A late-stage study of saxagliptin, developed by Bristol-Myers Squibb Co. (BMY) and AstraZeneca ...

FDA Panel Rejects Wider Use Of Painkiller 5/18/2008

A Food and Drug Administration panel didn't recommend approving expanded use of Cephalon Inc.'s ...

Roche: New Data On Actemra Shows Benefits In RA 5/18/2008

Swiss drugmaker Roche Holding AG (RHHBY) said Friday that Actemra can significantly inhibit ...

Generic May Challenge Sanofi, Bristol's Plavix In Europe 5/18/2008

Sanofi-Aventis SA and Bristol-Myers Squibb Co. are facing possible generic competition in Europe ...

GlaxoSmithKline To Study Tykerb In Early Breast Cancer 5/18/2008

GlaxoSmithKline PLC (GSK) said Monday it is starting a late-stage clinical trial that will study ...

Amgen: Study Shows Drug Raises Bone Mineral Density 4/13/2008

Amgen Inc. (AMGN) said its two-year Phase III study showed that twice-yearly injections of its ...

Schering Plans Cuts Of $1.5 Billion By 2012 4/13/2008

Schering-Plough Corp. announced a plan to cut costs by $1.5 billion by 2012, after a panel of ...

Studies Find Genetic Variation Linked To Lung Cancer Risk 4/13/2008

A trio of papers published Wednesday identifies for the first time a specific genetic variation ...

J&J Antibiotic Hits a Bump 3/26/2008

The Food and Drug Administration requested additional information from Johnson & Johnson and ...

Cephalon Bets On Cancer Drug 3/26/2008

Cephalon Inc. is hoping its move into the lucrative cancer market gets a boost this week with a ...

Genetics May Bring New Life To Failed Drugs 3/26/2008

As pharmaceutical makers find it increasingly difficult to bring new drugs to market, they are ...

Roche: Actemra Phase III Study Shows Benefits In RA 3/26/2008

Swiss drugmaker Roche Holding AG (RHHBY) said Tuesday that new data from a phase III study on ...

Novartis' Femara Halves Risk Of Breast Cancer Return 3/14/2008

Treatment with Novartis AG's (NVS) Femara can halve the risk of breast cancer returning even when ...

Eli Lilly Drops Inhalable-Insulin Product 3/14/2008

Eli Lilly and Co. is becoming the latest drug maker to abandon the once-promising concept of ...

Boost For Off-Label Drug Use 2/25/2008

The Food and Drug Administration wants to allow drug companies to give doctors information about ...

FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution 2/25/2008

UCB (Euronext: UCB) and sanofi-aventis announced today that the U.S. Food and Drug Administration ...

FDA Nears Ruling On Use Of Avastin For Breast Cancer 2/25/2008

Genentech Inc. has been waging an uphill fight to add breast-cancer treatment to the approved ...

Heart Attacks, Death Linked To Halting Plavix 2/14/2008

Patients treated for heart attack or angina and given the anticlotting drug Plavix had a sharply ...

Study May Help Effort To Widen Avastin Use 2/14/2008

Genentech Inc. said a study showed that its cancer drug Avastin slowed the growth of ...

Enzyme May Help Pancreatic Cancer Hide 2/5/2008

Cancer cells in the lymph nodes of patients with pancreatic cancer appear to produce enough of a ...

Novartis Meningitis Vaccine Shown To Work In Infants 1/27/2008

Swiss drug maker Novartis AG said its Menveo vaccine promises to be effective in protecting ...

Antidepressants Under Scrutiny Over Efficacy 1/27/2008

The effectiveness of a dozen popular antidepressants has been exaggerated by selective ...

Bayer Gets US Marketing Approval For rThrombin Drug 1/27/2008

German pharmaceutical and chemicals company Bayer AG (BAY.XE) Thursday said it received approval ...

Genentech Finds Lupus-Linked Genes 1/27/2008

Genentech Inc.'s discovery of two new genes linked to lupus raised hopes of earlier diagnosis ...

Study Ties Long-Term Birth Control Pill Use To Heart Risks 11/16/2007

A troubling study from Belgium hints that long-term use of oral contraceptives - at least the ...

Merck KGaA Files For EU OK For Sapropterin HPA Indication 11/16/2007

Merck KGaA said Thursday its division Merck Serono submitted an application to the European ...

AstraZeneca's Crestor Gets FDA OK For Atherosclerosis 11/16/2007

AstraZeneca PLC (AZN) Friday said its cholesterol-lowering drug Crestor has been approved in the ...

FDA Approves Over-The-Counter Zyrtec Allergy Drug 11/16/2007

The Food and Drug Administration said Friday it's approved Zyrtec-D, an allergy drug, as an ...

Abbott Gets FDA Approval For Lower-Strength HIV Drug 11/16/2007

Abbott Laboratories (ABT) received Food and Drug Administration approval for a new ...

Avastin, Tarceva Trial Doesn't Meet Primary Endpoint 11/16/2007
Swiss drugmaker Roche Holding AG (RHHBY) said Tuesday that data from the phase III AVITA trial ...
European Patent Office Revokes AstraZeneca Symbicort Patent 10/19/2007

The European Patent Office said Thursday said that it is revoking a patent for AstraZeneca PLC's ...

FDA Expands Use Of Sanofi's Meningitis Vaccine 10/19/2007

The Food and Drug Administration said Thursday it expanded the approved age range for Menactra, ...

FDA Panel Studying Children's Cold Medicine Safety 10/19/2007

A Food and Drug Administration panel of outside medical experts is weighing whether ...

Aastrom Says Bone Repair Cells Improved Healing Rates 10/19/2007

Aastrom Biosciences Inc. (ASTM) said results of a Phase I/II clinical trial showed that ...

FDA: Sudden Hearing Loss Linked To Impotence Drugs 10/19/2007

The U.S. Food and Drug Administration said Thursday it's approved new erectile dysfunction drug ...

Actelion: Zavesca Gets Negative Opinion From EU Drug Regulator 10/19/2007

Swiss pharmaceutical company Actelion Ltd (ATLN.VX) said Friday that the European Committee for ...

Medtronic Pulls Defibrillator Wires Off Market 10/18/2007

Medical-device maker Medtronic Inc. (MDT) is suspending sales of an electrical wire that ...

J&J: FDA Approves Doribax For Intra-Abdominal UTIs 10/18/2007

The Food and Drug Administration approved Doribax as a new treatment for complicated ...

FDA Approves Merck HIV Drug Isentress 10/18/2007

The U.S. Food and Drug Administration Friday approved a new type of HIV drug from Merck & ...

Sanofi Pasteur Sets Up Partnership For Malaria Vaccine 10/18/2007
p> Sanofi Pasteur, the vaccines division of Sanofi-Aventis (SNY), announced Monday a partnership ...
Bayer Says New MS Agent Demonstrated Robust Treatment Effect 10/18/2007

German pharmaceutical and chemicals company Bayer AG (BAY.XE) Monday said its new multiple ...

Genentech To Limit Avastin Availability 10/14/2007

Genentech Inc. said it will stop making its cancer drug Avastin available to certain pharmacies ...

BioXell Share Price Spikes On Strong Trial Data 10/14/2007

Bioxell SpA's (BXLN.EB) share price Friday spiked 7.8% after the Italian biopharmaceutical ...

Teva Pharma Says Copaxone Slows Progression Of Disability 10/14/2007

Teva Pharmaceutical Industries Ltd. (TEVA) said Friday that data from a 16-year follow-up study ...

NPS Pharma's Gattex Study Shifts Spotlight To Nycomed 10/14/2007

NPS Pharmaceuticals Inc.'s (NPSP) disappointing trial data may do more than shave off a quarter ...

12345

Drug Pipeline List




Drug Pipeline Copyright © 2005- 2017 All Rights Reserved.